Barimbao, Marygrace .

HRN: 04-16-39  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2023
CEFUROXIME 1.5GM (VIAL)
09/29/2023
10/05/2023
IV
1.5 G
Q8
Sp CS
Waiting Final Action 
09/29/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
09/29/2023
10/05/2023
IV
500mg
Q8
Sp CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: